Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sandoz Group Ltd ( (CH:SDZ) ) just unveiled an announcement.
Sandoz has signed a 10-year virtual Power Purchase Agreement with Elawan Energy to develop 150 MW solar projects in Spain, covering nearly 90% of its European electricity demand. This initiative is a significant step in Sandoz’s decarbonization strategy, aligning with its commitment to sustainability and reducing its environmental footprint.
The most recent analyst rating on (CH:SDZ) stock is a Buy with a CHF50.00 price target. To see the full list of analyst forecasts on Sandoz Group Ltd stock, see the CH:SDZ Stock Forecast page.
More about Sandoz Group Ltd
Sandoz is a global leader in generic and biosimilar medicines, headquartered in Basel, Switzerland. With a history dating back to 1886, the company offers a portfolio of approximately 1,300 products addressing a range of diseases from the common cold to cancer. Sandoz employs over 20,000 people worldwide and is committed to pioneering access for patients, generating significant healthcare savings and social impact.
Average Trading Volume: 986,530
Technical Sentiment Signal: Buy
Current Market Cap: CHF20.81B
See more insights into SDZ stock on TipRanks’ Stock Analysis page.